Objetivos: establecer si en Colombia en pacientes con fibrilación auricular no valvular (FA)
el uso de los nuevos anticoagulantes orales (NACO) son costo útiles cuando se comparan …

Atrial fibrillation (AF) is the most common cardiac arrhythmia with an increased risk of stroke
and mortality. Effective stroke prevention leads to an improved quality of life and a lower …

A key treatment for atrial fibrillation (AF) is stroke prevention with oral anticoagulants. The
landscape of treatment has been changing due the availability of non-vitamin-K antagonist …

The disease burden related to atrial fibrillation (AF) has been acknowledged for many years.
An overall prevalence of 3% in the adult population might not be perceived as high, however …

Background The use of direct oral anticoagulants (DOAC) for stroke prevention in non-
valvular atrial fibrillation (NVAF) has not been previously assessed in our setting. We aimed …

No evidence for an association between renal function and serious bleeding events in
patients treated with coumarins BACKGROUND Although anticoagulation therapy is closely …

METHODS It was a randomized, prospective, open-label, comparative study conducted
among Cardio-Thoraco-Vascular Surgery (CTVS) inpatients and outpatients at Vydehi …

Dit onderwijsprogramma staat niet op zich. Het is gemaakt in lijn met het onderwijs aan de
geneeskundefaculteiten en het voorschrijfexamen dat op diverse faculteiten wordt …

Background: In randomized clinical trials direct oral anticoagulants (DOAC) were shown to
be safe and effective in atrial fibrillation (AF) patients and were rapidly taken up in clinical …